Assertion list for term "placebo".

Results from Ascent++: 137
effect (aspect of placebo) HasPropertyunknown 0.77
placebo HasPropertyeffective 0.67
effect (aspect of placebo) HasPropertyconsistent 0.63
placebo HasAeffect 0.58
placebo CapableOfreduce pain 0.56
effect (aspect of placebo) HasPropertysignificant 0.55
effect (aspect of placebo) ReceivesActionobserved 0.54
effect (aspect of placebo) HasPropertytemporary 0.54
effect (aspect of placebo) HasPropertyreversible 0.53
placebo ReceivesActionused as control 0.53
effect (aspect of placebo) HasPropertyrare 0.53
effect (aspect of placebo) HasPropertygreater 0.51
effect (aspect of placebo) HasPropertyminimal 0.50
placebo HasPropertypowerful 0.50
placebo CapableOfwork 0.50
placebo HasAactive ingredients 0.48
effect (aspect of placebo) HasPropertymild 0.48
effect (aspect of placebo) ReceivesActionassessed 0.47
effect (aspect of placebo) HasPropertystrong 0.45
placebo HasPropertyhelpful 0.43
placebo ReceivesActionintroduced into medical research 0.43
effect (aspect of placebo) HasPropertyapparent 0.42
placebo HasPropertynegative 0.41
placebo ReceivesActionadded to existing therapy 0.40
effect (aspect of placebo) HasPropertyreal 0.39
placebo HasPropertyinactive 0.39
placebo HasAdirect effect 0.38
placebo CapableOflook like the study drug 0.38
placebo HasAwide range of responses 0.38
placebo HasAtherapeutic effect 0.37
effect (aspect of placebo) HasPropertymore pronounced 0.37
effect (aspect of placebo) HasPropertypsychological 0.37
effect (aspect of placebo) HasPropertysmaller 0.37
effect (aspect of placebo) ReceivesActionassociated with increasing doses 0.37
effect (aspect of placebo) CapableOfgain early evidence of effectiveness 0.37
effect (aspect of placebo) ReceivesActioncaused by the treatment 0.37
effect (aspect of placebo) CapableOfhappen 0.37
placebo CapableOfmatch zopiclone 0.36
placebo ReceivesActiongiven in addition 0.36
placebo ReceivesActiontaken at bedtime 0.35
placebo CapableOflook like investigational medication 0.35
placebo ReceivesActionadded to insulin 0.35
effect (aspect of placebo) HasPropertystronger 0.34
effect (aspect of placebo) ReceivesActionsustained 0.34
effect (aspect of placebo) HasPropertyvariable 0.34
effect (aspect of placebo) ReceivesActionreported 0.34
placebo CapableOflook like medicine 0.33
placebo DefinedAssubstance 0.33
placebo HasPropertysafe 0.33
placebo ReceivesActioncompared 0.33
effect (aspect of placebo) HasPropertyunreliable 0.31
placebo HasPropertyunethical 0.31
placebo DefinedAsprocedure 0.31
placebo ReceivesActiongiven same way 0.31
effect (aspect of placebo) HasPropertyunpredictable 0.31
placebo HasPropertygood 0.30
effect (aspect of placebo) ReceivesActionfelt 0.30
effect (aspect of placebo) ReceivesActiontested 0.30
effect (aspect of placebo) ReceivesActionmonitored 0.30
drink HasAplacebo 0.29
placebo ReceivesActionadministered without deception 0.28
placebo ReceivesActiontitrated 0.28
placebo HasPropertyactive 0.28
placebo CapableOfrelease much dopamine 0.28
placebo CapableOfleave the area 0.28
placebo ReceivesActiondiscontinued 0.28
placebo ReceivesActionmatched to sumatriptan 0.28
placebo HasPropertysmall 0.28
placebo HasPropertyineffective 0.28
effect (aspect of placebo) ReceivesActionexpected 0.27
placebo ReceivesActionintended to deceive the recipient 0.26
effect (aspect of placebo) HasPropertyshort-lived 0.26
placebo ReceivesActiongiven in clinical context 0.25
placebo ReceivesActiondosed in the morning 0.25
placebo CapableOfevoke understood medical benefits 0.25
placebo ReceivesActioncompared to fluoxetine 0.25
placebo ReceivesActioncompared to venlafaxine 0.25
placebo HasAaspartame 0.25
placebo CapableOffeel like actual treatment 0.25
placebo ReceivesActionmatched for taste 0.25
placebo HasPropertyreal 0.25
placebo CapableOfcure cancer 0.25
placebo ReceivesActionadded to current aed treatment 0.25
placebo HasSubeventcase 0.25
placebo HasSubeventlessening 0.25
placebo HasSubeventelimination of pain 0.25
placebo ReceivesActionstarted 0.25
placebo ReceivesActionadded to metformin 0.25
placebo HasAsame appearance 0.25
placebo ReceivesActionused to test the effectiveness of treatments 0.25
placebo ReceivesActionadministered as sublingual tablet 0.25
placebo CapableOfrelieve anxiety 0.25
placebo CapableOfrelieve postoperative pain 0.25
placebo CapableOfchange the blood chemistry of patients 0.25
effect (aspect of placebo) HasPropertynegative 0.25
effect (aspect of placebo) HasPropertyindependent 0.25
effect (aspect of placebo) RelatedToelevated prolactin levels 0.25
effect (aspect of placebo) ReceivesActionassociated with antidepressant 0.25
effect (aspect of placebo) HasPropertymore marked 0.25
effect (aspect of placebo) ReceivesActionassessed by coronary angiography 0.25
effect (aspect of placebo) ReceivesActioncorroborated by similar findings 0.25
effect (aspect of placebo) ReceivesActionevaluated in patient 0.25
effect (aspect of placebo) HasPropertybrief 0.25
shampoo HasAplacebo 0.25
effect (aspect of placebo) ReceivesActionmaintained 0.25
placebo AtLocationtension-type headache 0.24
effect (aspect of placebo) HasPropertyserious 0.21
effect (aspect of placebo) ReceivesActionenhanced 0.21
effect (aspect of placebo) HasPropertypossible 0.21
effect (aspect of placebo) HasPropertysevere 0.21
effect (aspect of placebo) HasPropertybeneficial 0.21
placebo HasPropertysuccessful 0.20
placebo Causesside effects 0.20
placebo CapableOfactivate body's μ-opioid endorphin system 0.20
placebo CapableOfreceived undue credit 0.19
placebo CapableOfimprove a patient's condition 0.16
placebo ReceivesActionconsidered controversial 0.16
placebo ReceivesActionprescribed under deception 0.16
placebo ReceivesActiondesigned to be harmless 0.16
placebo HasAmedicinal properties 0.16
placebo CapableOfshrink tumor 0.16
placebo CapableOfchange the way 0.16
placebo AtLocationepisodic migraine 0.16
placebo HasAsuch a profound effect 0.16
placebo ReceivesActiondesigned to resemble the treatment 0.16
placebo CapableOfcome in any shape 0.16
effect (aspect of placebo) HasPropertylarge 0.16
effect (aspect of placebo) CapableOfpersist until the end of the trial 0.16
effect (aspect of placebo) HasPropertyhorrendous 0.16
effect (aspect of placebo) ReceivesActionseen in the 2m/kg group 0.16
effect (aspect of placebo) ReceivesActiondifficult to identify 0.16
effect (aspect of placebo) HasPropertycommon 0.16
effect (aspect of placebo) HasPropertysuperior 0.16
effect (aspect of placebo) CapableOflast for any duration of time 0.14
effect (aspect of placebo) ReceivesActionobserved in cynomolgus monkeys 0.09
placebo CapableOfcure disease 0.03
placebo CapableOfpresented benefit 0.00